The mouse Insulin-like growth factor II gene (Igf2) Is transcribed from three promoters (P1, P2 and P3), and Is expressed in a tissue-specific and developmentally regulated fashion; however, little information Is available on the transcription factors controlling Igf2 expression. The AP-1 complex is a transcription factor Involved In the regulation of a variety of genes, including those encoding certain growth factors. We show that Igt2 P3 Is transactlvated by AP-1 in a transient expression assay, and that this effect Is mediated through two non-consensus AP-1 binding sites characterised by DNA-protein Interaction studies. Mutatlonal analysis Indicates these sites are required for AP-1 responsiveness and full promoter activity.
INTRODUCTION
The insulin-like growth factors (IGF-I and IGF-II) are mitogenic polypeptides displaying structural similarities to proinsulin (1, 2) . IGF-II is required for normal pre-natal growth in the rodent (3) and is encoded by a complex transcriptional locus, comprising three promoters and multiple polyadenylation signals (4, 5) . In the rodent embryo, IGF-II gene transcripts can be detected in a variety of tissues and offer an example of temporal and spatial regulation of gene expression with transcript levels declining after birth in most tissues (6, 7, 8) . There is as yet little information available regarding transcription factors which address the IGF-II gene promoters. Promoters of the human gene have been most extensively characterized (9, 10, 11, 12) . Drummond etal (13) have recently reported a repression of human IGF-II promoter 3 (similar in sequence to promoter 2 of the rodent gene) by the product of the Wilms' tumour susceptibility gene. Studies carried out on promoter 3 (P3) from the rat gene (14, 15) indicate that this promoter possesses a compact structure, requiring for maximal activity no more than 128 bases upstream of exon 3, including a TATA box and binding sites for the Spl transcription factor.
In this paper we describe the transactivation of Igft promoters by AP-1 in a transient expression system using CP-1 embryonic stem (ES) cells, which present low endogenous levels of Igfl and AP-1 binding activity. DNA-protein interaction studies demonstrate the presence of two AP-1 binding sites in the proximal promoter region and, following their mutation, they were found to be necessary for AP-1 transactivation and full promoter activity. During embryonal carcinoma (EC) and embryonic stem (ES) cell differentiation Igfl and c-jun mRNA levels, and AP-1 binding activity, have been shown to increase (16, 17, 18 and this paper), raising the possibility that AP-1 might be involved in the induction of Igfl expression in this system.
MATERIALS AND METHODS Ceils
Buffalo Rat Liver cells (BRL cells; 19) were grown at 37°C, 5% CO2 in alpha-Ham's medium (Gibco-BRL) supplemented with 10% fetal calf serum (Hyclone), ampicillin (75mg/l), streptomycin (50mg/l) and 50rnM £-mercaptoethanol. BRL conditioned medium was harvested every three days and employed in the preparation of the ES cell culture medium. Mouse CP-1 ES cells (20) were grown in a 7:3 (vol:vol) ratio of BRL conditioned medium to alpha-Ham's medium (supplemented as above), at 37°C, 5% CO? (21) . CP1 cells utilised for differentiation studies were cultured in the absence of BRL conditioned medium for 10 days prior to use. Differentiation was monitored by checking the levels of the stagespecific surface antigens SSEA-1, SSEA-4 and laminin. Although CP-1 cells cultured in the presence of BRL CM did not display a significant SSEA-1-positive reaction, they proved to be negative for laminin expression; low levels of SSEA-4 antigen were also detected (up to 10% of the cells). Withdrawal of BRL CM from the medium for 10 days resulted in an increase in the number of SSEA^*-positive cells (up to 20% of the cells) and lamininpositive cells (up to 30%). created in the pLUC and pLUCS vectors, containing the firefly (Photinus pyralis) luciferase coding region and the SV40 small t intron and polyadenylation signal (24; Figure 3a ). All mouse IGF-II gene nucleotide positions refer to transcript initiation sites defined by Rotwein and Hall (23) . Mouse Igfl promoter PI was isolated as a 2.2 Kb BamHl fragment including the two 5'-most transcriptional start sites of exon 1, and cloned into pLUC, giving rise to pPl. P2 and P3 were sub-cloned from cosIGF4 within a 5.6 kb BamHl fragment (from nucleotide position -42 5' of the third transcriptional initiation site in exon 1, to nucleotide position +11 within exon 4) and inserted into pBluescriptSK + (Stratagene) to form pP2P3. P2L was constructed by inserting into pLUC a 2.0kb Pstl fragment from pP2P3 utilising sites in the poly linker sequence 5' of the insert and at position +383 in exon 2. For the construction of luciferase fusions with P3 sequences, the Igfl translational initiation codon (present in exon 4 at position +7) was eliminated by sub-cloning the insert from pP2P3 into pUC19 (Pharmacia) as a Kpnl fragment, utilising sites within the poly linker of pBluescriptSK + , 5' of the pP2P3 insert and within exon 4 (from position -1 to position +5). This step created the clone pKP2P3. pP3L was derived from pKP2P3 by cloning into pLUC a Pstl-BamHl fragment comprising sequences between the Pstl site at position +383 in exon 2 and the BamHl site in the polylinker sequence 3' of the insert. pP3M is a derivative of pP3L, lacking all Igfl genomic sequences upstream of the Nhel site at position -162 5' of exon 3. To generate pP3MM and pWTluc an Nhel-BgH (-162 to +74 with respect to exon 3) fragment was rendered blunt-ended with the Klenow fragment of E.coli DNA polymerase I and cloned into a deletion derivative of pBluescriptSK + (lacking polylinker sequences from the Xbal site to the Xhol site) giving rise to the intermediate clone pBstP3, from which it could be recovered as a Xbal-Xhol fragment including only 22bp of polylinker sequence (17 base pairs 5' and 5 base pairs 3' of the insert). The Xhol-Xbal fragment was then also rendered blunt-ended and ligated either into pLUC (at the BamHl site rendered blunt-ended) or into pLUCS (at the StuI site), generating pP3MM and pWTluc respectively. Mutagenesis of the two AP-1 sites was achieved by PCR, utilising pBstP3 as a template. For each site, 2 primer pairs were used (lower case indicates substituted bases): for site 1 (nucleotide position -39 to -29 with respect to exon 3) pair a: M13 reverse sequencing primer (5'AACAGCTATGACCA-TG3') and MIGFP3-31 (5'gggGACATAAAAAGCGGAGG3')j pair b: M13 -20mer (5'GTAAAACGACGGCCAGT3') and M-IGFP3-34 (5'GgGGCTCCTCCCAGTCCCGG3'). For site 2 (nucleotide position -92 to -80) primer pair c: M13 reverse sequencing primer and MIGFP3-35 (5'cCtGCAGGGAGGGG-GTGGGGGGTA3'); pair d: M13 -20mer and MIGFP3-36 (5'CCtCTCCCCCCGCCCCCTTT3'). Each PCR amplified fragment was sub-cloned into pBluescriptSK +. The insert pairs indicated were then ligated together to generate derivatives of pBstP3 lacking AP-1 sites (pPCRl, with mutations within site 1 generating a Smal site; pPCR2, with mutations within site 2 generating a StuI site). The generation of a pBstP3 version lacking both AP-1 sites (pPCR3, containing a Smal site and a StuI site) was achieved by using pPCRl as a template and primer pairs c and d for the PCR reactions, followed by sub-cloning as for pPCRl and pPCR2. The inserts from pPCRl, pPCR2 and pPCR3 were excised as Xbal-Xhol fragments, rendered blunt-ended and sub-cloned into the StuI site of pLUCS generating transcriptional fusions (pPCRlluc, pPCR21uc and pPCR31uc) identical to pWTluc except for the desired mutations (as determined by DNA sequencing).
The mouse c-jun and c-fos expression vectors have been reported previously (25) and were provided by Dr Michael Karin (University of California, San Diego). The pSV2ALA5', pSV0ALA5' (26: in this paper abbreviated to pSV2 and pSVO respectively) and pIRV-Neo-Act-LacZ (27; referred to in this paper as pIRV) plasmids were provided by Dr Suresh Subramani (University of California, San Diego) and Dr Rosa Beddington (University of Edinburgh). The mouse Igfl and GAPDH cDNAs (28, 29) employed to probe Northern blots were supplied by Dr Graeme Bell (Chiron Corporation, California), and Dr J.K.Heath (Oxford, UK).
RNA isolation and analysis Approximately 3/xg samples of polyadenylated RNA (30, 31) were electrophoresed in formaldehyde/1 % agarose gels (22) 6 cells/ml; plasmid DNAs, resuspended in serum-free alpha-Ham's medium at a concentration of lmg/ml were added as indicated in the results section. In most experiments, the total amount of DNA added to each sample was adjusted to 70/tg with pBluescriptSK +, and the final volume in each cuvette was adjusted to 500/d with serumfree alpha-Ham's medium. For direct comparisons between pWTluc and pPCR31uc constructs, cells were transfected with 20/ig of either construct and 10/tg pIRV. Electroporation was carried out using a Biorad Gene Pulser, equipped with capacitance extender, at 250V, 500/tFD. After a 15 minute incubation at 20°C, cells were transferred to 9ml serum supplemented medium in 10cm diameter tissue culture dishes and cultured for 12 hours. This time point was found to be optimal following electroporation of promoter-luciferase constructs in preliminary experiments (data not shown).
Luciferase and /3-galactosidase enzyme activities were measured with an Autolumat LB 953 luminometer (Berthold) and Titertek multiscan MCC/340 spectrophotometer respectively, using reagent kits supplied by Promega (following manufacturer's instructions). Amounts of soluble protein contained in cell lysates were measured spectrophotometrically using the Protein Assay Dye reagent (Biorad) as per manufacturer's instructions. Luciferase readings were adjusted relative to protein levels and to /3-galactosidase activity in order to control for variations in transfection efficiency and cell number. Background readings obtained from control samples (cells electroporated in the absence of plasmid DNAs) were subtracted from the readings obtained from experimental samples (cells electroporated in the presence of Igfl promoter-luciferase constructs). Transient expression experiments were repeated at least three times, with all samples being treated in duplicate on each occasion.
DNA gel-shift assays Preparation of nuclear extracts was according to Andrews and Faller (32) . 5/tg of nuclear proteins were incubated with 7/tg polydldC (Sigma) in 25mM Tris-HCl (pH 8), 50mM KC1, 6.25mM MgCl 2) 0.5mM EDTA, 10% glycerol, 0.5mM DTT for 10 minutes at 20°C in a final volume of 30/d; a 50-fold excess of unlabelled competitor oligonucleotide, comprising either an AP-1 specific oligonucleotide (5'CGCTTGATGAGTCAGCC-GGAA3', Promega) or an Spl specific (control) oligonucleotide (5'ATTCGATCGGGGCGGGGCGAGC3', Promega) was added. Probe, 0.1-Ing AP-1-specific oligonucleotide endlabelled with T [
32 P]dATP (3000Ci/mM, NEN-Dupont) to a specific activity of 5 -10xl0 7 cpm//tg, was then added and incubation was continued for a further 10 minutes prior to gel loading. DNA-protein complexes were separated on 8% nondenaturing polyacrylamide gels poured and run in 1XTBE buffer (Tris-Borate-EDTA, pH 8).
DNAse I footprinting
Footprinting reactions were performed using purified human cjun protein (Promega) according to manufacturer's instructions, except that binding reactions were carried out at 20°C for 10 minutes. Following protein binding, 1 -5ng of the probes (either pBstP3, singly labeled at a Xhol site or the SV40 early promoterenhancer region, singly labelled at an EcdKL site, end-labelled to a specific activity of 2-4X10 6 cpm//tg) were subjected to DNAse I digestion using 0.02 units of DNAse I (Promega) for 1 minute at 20 °C in a 50/tl reaction volume. Reactions were terminated by addition of 2x stop buffer (0.2M NaCl, 0.03M EDTA, 1% SDS, 100/ig/ml yeast tRNA), followed by phenolchloroform (phenol:chloroform:isoamyl-alcohol; 24:24:1) extraction and ethanol precipitation. DNA pellets were resuspended 1:1 (v/v) in water:loading dye (loading dye: 0.1 M NaOH/formamide 1:2 v/v, 0.1% xylene cyanol, 0.1% bromophenol blue) and separated on 6% denaturing polyacrylamide gels. Footprinted regions were analyzed by comparison with DNA sequence obtained with Sequenase 2 reagents (United States Biochemical), using pBstP3 as a template and priming the reaction with a primer (5'TCGAGGGGCTGG-AAGAGG3') in which the 5'-most base was the same as the endlabelled base of the probe (pBstP3) used in Igfl P3 footprinting reactions.
RESULTS

AP-1 activity and Igfl transcript levels are induced upon CP-1 cell differentiation
In order to monitor AP-1 activity, nuclear extracts were prepared from CP-1 ES cells cultured in the presence and absence of BRL cell conditioned medium. 5/tg of nuclear proteins from each extract were employed in gelshifts utilising a double stranded oligonucleotide containing the AP-1 recognition sequence (TG-ACTCA, Figure 1) . A substantial increase in AP-1 binding activity was observed upon CP-1 ES cell differentiation (Figure 1,  lanes 2 and 3) . Competition with unlabelled AP-1 specific (lane 4) and Spl specific oligonucleotides (lane 5) demonstrates the specificity of binding. We note that in some experiments, as in the example presented here, some competition by the Spl-specific oligonucleotide was observed. However, experiments using various amounts of competitor oligonucleotides demonstrate that an AP-1-specific competitor was effective at much lower concentrations than competitor oligonuclotides bearing consensus binding sites for Spl, Oct-1, and the glucocorticoid receptor (data not shown). These results are consistent with those reported previously by de Groot et al (17) following retinoic acid-induced differentiation of ES cells. Igfl transcript levels were found to rise upon CP-1 ES cell differentiation (Figure 2 promoters were isolated from the mouse cosmid clone cosIGF4 (23) . The constructs pPl, pP2 and pP3L produced luciferase in BRL cells, which have been previously shown to express abundant levels of IGF-II transcripts (6), and did not do so when die orientation of the Igfl sequences with respect to the luciferase coding region was reversed (data not shown). Each Igfl promoterluciferase construct (Figure 3a) was then tested in a transient expression assay for transactivation by cotransfected mouse cjun and c-fos expression vectors in CP-1 cells, which have relatively low levels of Igfl transcripts ( Figure 2 ) and endogenous AP-1 activity (Figure 1 ). An induction of luciferase activity in die presence of c-jun and c-fos expression vectors was observed for pP3 (up to 15-fold, Figure 3b ), and pPl constructs (2 to 3-fold, Figure 3c ). The pSV2 construct (26) , containing the luciferase coding region driven by the SV40 early promoterenhancer, was used as a control for AP-1 transactivation; this promoter has previously been shown to bind AP-1 (33, 34) and to respond to phorbol ester treatment (35) . Further characterisation of the effect of AP-1 on Igfl expression focussed on the elements contained in P3 which had shown the strongest response. By assaying progressively smaller regions of the third promoter of the IGF-II gene it was possible to delimit a segment of approximately 24Obp (pP3MM, containing nucleotides -162 to +74 with respect to exon 3; Figure 3a ) which was still capable of responding to co-electroporated c-jun and c-fos expression constructs (Figure 3b) . However, no canonical AP-1 sites were observed in this stretch of sequence.
AP-1 binding sites within Igfl P3
The transactivation assays identified a 240bp responsive region in P3 (pBstP3). DNAse I footprinting of this region was carried out using human recombinant c-jun protein (Figure 4) . Two nonconsensus binding sites were identified in the proximal P3 promoter region (site 2, at position -92: GGAGTGGTCAGC and site 1, at position -39: GAGCCACTCAGA, underlining indicates regions of homology to die canonical AP-1 recognition site), as shown in Figure 4b . As a control, footprinting was carried out on die SV40 early promoter-enhancer to demonstrate specific binding to a previously characterised AP-1 site (TTA-GTCA, 34) with these experimental conditions (Figure 4c ). Footprinting carried out on the pBstP3 template at increasing KC1 concentrations indicates AP-1 site 2 to be a higher affinity JUN binding site than site 1 (data not shown). 
Functional analysis of the AP-1 sites in Igfl promoter 3
The functional importance of the AP-1 binding sites identified in Igfl P3 was analysed following polymerase chain reaction (PCR) mediated mutagenesis (Figure 5a ). Derivatives of pBstP3 were created containing base substitutions in the AP-1 binding site at position -39 (site 1: CCACTCA in pBstP3 mutated to CCCGGG in pPCRl), in the AP-1 site at position -92 (site 2: TGGTCA in pBstP3 mutated to AGGCCT in pPCR2) and in both sites (sites 1 and 2 mutated in pPCR3). Loss of AP-1 binding to the mutated sites in pPCRl, pPCR2 and pPCR3 was confirmed by gelshift and footprinting analyses (data not shown).
The functional importance of die footprinted sites in Igfl P3 was demonstrated by co-electroporation of c-jun and c-fos expression vectors in transactivation assays utilising the wild type (pWTluc) and mutated (pPCRlluc, pPCR21uc and pPCR31uc) Table 1 ). Only site 2 is fully conserved between rat, mouse and human Igfl P3 sequences ( Figure 6 ) and it is interesting to note that significant differences in relative promoter strength exist between the rodent and human promoters. P4 of the human gene (equivalent to the rodent P3 promoter) appears to be a minor promoter as judged by functional studies and by Northern analysis 
(9), while in rodents P3 seems to be a major contributor to the Igfl transcript family (4) and the strongest promoter in the mouse gene as judged by transient transfection studies (Caricasole and Ward, unpublished data) . Such species-specific differences in relative P3 promoter strength could be accounted for, at least in part, by qualitative or quantitative variations in transcription factor binding to the P3 promoter region. In this respect it is noteworthy that the human equivalent of mouse AP-1 site 1 deviates considerably from its rodent counterparts and from the AP-1 consensus binding site. Similarly, van Dijk et al (9) failed to observe protection on the human P3 promoter of sequences bound by Spl in the rat P3 region (14) , despite extensive sequence homology ( Figure 6 ), and the employment of nuclear extracts from the same cell line (HeLa cells) for footprinting reactions. The non-synergistic nature of the action of the two Igfl P3 AP-1 sites (Figures 5b and 5c ) is consistent with the study of Angel et al (33) in which multiple TRE elements were introduced into a heterologous promoter. In at least one other case, that of the tissue plasminogen activator type 2 gene (PAI-2), the presence of two AP-1 binding sites in the promoter region has been shown to be necessary for both basal and phorbol ester-inducible transcriptional activity (38) . Studies in BRL cells using Igfl P3 constructs, either with intact (pWTluc) or mutated AP-1 sites (pPCR31uc) suggest these sites are necessary for full promoter activity (data not shown), drawing a parallel with the PAI-2 gene promoter. Examination of the Igfl P3 sequence suggests further similarities with the promoters of other AP-1 responsive genes (Figure 6 ), in particular the presence of motifs resembling binding sites for the PEA3 transcription factor (consensus AGGAAG/A; 37,44).
In the developing rodent embryo, significant overlaps in the domains of expression of members of the jun and fos gene families and of the IGF-II gene exist (39, 40, 41) , in particular in skeletal muscle and developing bone and cartilage, which is consistent with a role for AP-1 in the regulation of IGF-II expression in at least some tissues of the embryo. In the rat, the developmental pattern of Igfl mRNA distribution (7, 41) closely resembles that of another AP-1 responsive growth factor gene, namely that encoding TGF/3-1 (42) .
The interaction between the AP-1 complex and Igfl promoter 3 may be of importance in the observed increase of steady-state Igfl message upon ES and EC cell differentiation (18) . Levels of c-jun message and AP-1 binding activity rise during both EC and ES cell differentiation (16, 17 and this paper), suggesting a role for AP-1 in differentiation-induced gene expression. However, when we introduced a range of Igfl promoterluciferase constructs (including P3-luciferase plasmids) transiently into ES cells cultured in the presence or absence of BRL conditioned medium the differentiation-dependent induction of endogenous Igfl expression (Figure 2) was not reproduced by the transfected constructs (data not shown), suggesting that, at least in a transient expression system, the AP-1 complex alone cannot mediate this effect. We are currently engaged in producing stably transformed ES cell lines with a variety of Igfl promoterreporter constructs to test the role of the AP-1 sites during ES cell differentiation. The study of differentiation-inducible gene expression in EC and ES cells has, in at least one case (that of the c-jun promoter; ref. 43) , shown that promoter constructs transiently introduced into cells failed to produce an induction that could account for the surge in mRNA levels observed for the endogenous gene; the same constructs, when stably transformed into cells, exhibited a strong (up to 180-fold) differentiation-dependent induction of promoter activity.
